| Dr Jay Herbert Rapley, MD | |
|
120 Ne Saint Lukes Blvd Ste 200, Lees Summit, MO 64086-6011 | |
| (816) 246-4302 | |
| (816) 246-8910 |
| Full Name | Dr Jay Herbert Rapley |
|---|---|
| Gender | Male |
| Speciality | Sports Medicine |
| Experience | 21 Years |
| Location | 120 Ne Saint Lukes Blvd Ste 200, Lees Summit, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295920718 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 746000949 (Texas) | Secondary |
| 207XX0005X | Orthopaedic Surgery - Sports Medicine | 2008010710 (Missouri) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rockhill Orthopaedic Specialists Inc | 5698935419 | 29 |
| Select Physical Therapy Holdings Inc | 9537076401 | 1487 |
News Archive
In an article to be published on 21 June 2010 in the Journal of Clinical Oncology, researchers from Inserm (Inserm unit 625 - Research Group on Human and Mammalian Reproduction, University of Rennes 1), the CHU (University Hospital Centre) in Pointe - Pitre (urology department, University of the French West Indies and Guiana) and from the Center for Analytical Research and Technology (University of Li-ge, Belgique), show that exposure to chlordecone (also named Kepone), an organochlorine chemical with well defined estrogenic properties used in the French West Indies until 1993, is associated to a significant increased risk of prostate cancer.
In a post in the Global Health Technologies Coalition's "Breakthroughs" blog, GHTC's Kim Lufkin reports on her travels to Kenya this month "to visit global health research projects and see the impact on people in the country," writing, "Although we visited a range of projects, I was left with the lasting impression that much of this research is so close to producing new health tools that can lead to amazing innovations in public health," including "the first ever malaria vaccine, gels women can use to protect themselves from HIV, and new drugs for neglected diseases that affect the poorest of the poor."
Noting the progress made since the beginning of the HIV/AIDS epidemic and the upcoming recognition of World AIDS Day on December 1, Ronald Valdiserri, deputy assistant secretary for health, infectious diseases at the Department of Health and Human Services, writes in a Public Health Reports opinion piece, "We would do well to keep in mind the following caution. No matter the elegance of the controlled trial, the statistical significance of the results, or the superiority of the science, we must confront this inevitable reality: We will never be able to take full advantage of our progress in HIV clinical and prevention science until we develop and sustain the human, organizational, and structural capacities necessary to implement these new scientific breakthroughs."
The first ads are already out based on the Congressional Budget Office report on the health law's impact on the labor market, and the Washington Post's Fact Checker finds plenty of distortions. Meanwhile, the White House seeks to persuade Americans that it's a good thing if the health care law means they can work less.
› Verified 4 days ago
| Entity Name | Rockhill Orthopaedic Specialists Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205321569 PECOS PAC ID: 5698935419 Enrollment ID: O20120331000052 |
News Archive
In an article to be published on 21 June 2010 in the Journal of Clinical Oncology, researchers from Inserm (Inserm unit 625 - Research Group on Human and Mammalian Reproduction, University of Rennes 1), the CHU (University Hospital Centre) in Pointe - Pitre (urology department, University of the French West Indies and Guiana) and from the Center for Analytical Research and Technology (University of Li-ge, Belgique), show that exposure to chlordecone (also named Kepone), an organochlorine chemical with well defined estrogenic properties used in the French West Indies until 1993, is associated to a significant increased risk of prostate cancer.
In a post in the Global Health Technologies Coalition's "Breakthroughs" blog, GHTC's Kim Lufkin reports on her travels to Kenya this month "to visit global health research projects and see the impact on people in the country," writing, "Although we visited a range of projects, I was left with the lasting impression that much of this research is so close to producing new health tools that can lead to amazing innovations in public health," including "the first ever malaria vaccine, gels women can use to protect themselves from HIV, and new drugs for neglected diseases that affect the poorest of the poor."
Noting the progress made since the beginning of the HIV/AIDS epidemic and the upcoming recognition of World AIDS Day on December 1, Ronald Valdiserri, deputy assistant secretary for health, infectious diseases at the Department of Health and Human Services, writes in a Public Health Reports opinion piece, "We would do well to keep in mind the following caution. No matter the elegance of the controlled trial, the statistical significance of the results, or the superiority of the science, we must confront this inevitable reality: We will never be able to take full advantage of our progress in HIV clinical and prevention science until we develop and sustain the human, organizational, and structural capacities necessary to implement these new scientific breakthroughs."
The first ads are already out based on the Congressional Budget Office report on the health law's impact on the labor market, and the Washington Post's Fact Checker finds plenty of distortions. Meanwhile, the White House seeks to persuade Americans that it's a good thing if the health care law means they can work less.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jay Herbert Rapley, MD 901 E 104th St, Kansas City, MO 64131-4517 Ph: (816) 502-8752 | Dr Jay Herbert Rapley, MD 120 Ne Saint Lukes Blvd Ste 200, Lees Summit, MO 64086-6011 Ph: (816) 246-4302 |
News Archive
In an article to be published on 21 June 2010 in the Journal of Clinical Oncology, researchers from Inserm (Inserm unit 625 - Research Group on Human and Mammalian Reproduction, University of Rennes 1), the CHU (University Hospital Centre) in Pointe - Pitre (urology department, University of the French West Indies and Guiana) and from the Center for Analytical Research and Technology (University of Li-ge, Belgique), show that exposure to chlordecone (also named Kepone), an organochlorine chemical with well defined estrogenic properties used in the French West Indies until 1993, is associated to a significant increased risk of prostate cancer.
In a post in the Global Health Technologies Coalition's "Breakthroughs" blog, GHTC's Kim Lufkin reports on her travels to Kenya this month "to visit global health research projects and see the impact on people in the country," writing, "Although we visited a range of projects, I was left with the lasting impression that much of this research is so close to producing new health tools that can lead to amazing innovations in public health," including "the first ever malaria vaccine, gels women can use to protect themselves from HIV, and new drugs for neglected diseases that affect the poorest of the poor."
Noting the progress made since the beginning of the HIV/AIDS epidemic and the upcoming recognition of World AIDS Day on December 1, Ronald Valdiserri, deputy assistant secretary for health, infectious diseases at the Department of Health and Human Services, writes in a Public Health Reports opinion piece, "We would do well to keep in mind the following caution. No matter the elegance of the controlled trial, the statistical significance of the results, or the superiority of the science, we must confront this inevitable reality: We will never be able to take full advantage of our progress in HIV clinical and prevention science until we develop and sustain the human, organizational, and structural capacities necessary to implement these new scientific breakthroughs."
The first ads are already out based on the Congressional Budget Office report on the health law's impact on the labor market, and the Washington Post's Fact Checker finds plenty of distortions. Meanwhile, the White House seeks to persuade Americans that it's a good thing if the health care law means they can work less.
› Verified 4 days ago
Dr. Matthew C. Daggett, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 Se Blue Pkwy, Suite # 230, Lees Summit, MO 64063 Phone: 816-525-2840 Fax: 816-525-2841 | |
Dr. Michael David Hellman, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 120 Ne Saint Lukes Blvd Ste 200, Lees Summit, MO 64086 Phone: 816-246-4302 Fax: 816-246-9493 | |
Dr. Gary Auson Go, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 120 Ne Saint Lukes Blvd Ste 200, Lees Summit, MO 64086 Phone: 816-246-4302 Fax: 816-246-8910 | |
Dr. Timothy P Roberts, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2861 Ne Independence Ave Ste 201, Lees Summit, MO 64064 Phone: 816-525-2840 Fax: 816-525-2841 | |
Dr. Gerald Francis Dugan, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 120 Ne Saint Lukes Blvd Ste 200, Lees Summit, MO 64086 Phone: 816-246-4302 Fax: 816-246-8910 | |
Dr. Larry Frederick Frevert, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 120 Ne Saint Lukes Blvd Ste 200, Lees Summit, MO 64086 Phone: 816-246-4302 Fax: 816-246-8910 |